Clinical trial

Implementation Strategies for Monitoring Adherence in Real Time

NCT04347161

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-02-22

PhaseNA

Study timeline

Study start (actual)2021-02-22Date precision: day

Registry last updated2026-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Medication Adherenceunresolved

Symptoms and Signsunresolved

Interventions

Conversational Agent/ChatbotDEVICE

Usual CareOTHER

Sponsors & collaborators

Abramson Cancer Center at Penn Medicinelead sponsor

Lung Cancer Research Foundationcollaborator

Pfizercollaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04347161 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.